Epcoritamab with rituximab + lenalidomide (R2) and epcoritamab maintenance deliver deep and durable remissions in previously untreated (1L) follicular lymphoma (FL): 3-year outcomes from epcore NHL-2 arms 6 and 7

Authors: Lori A. Leslie, Gerardo Musuraca, Pau Abrisqueta, Joshua Brody, Jacob Haaber Christensen, Alexander Fosså, Marjolein van der Poel, Joost S.P. Vermaat, Fritz Offner, David Belada, Jian Mei, Işıl Altıntaş
+4 more Malene Risum, Aidan Reilly, L Wang, Lorenzo Falchi
Cited by: 0

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Cutaneous lymphoproliferative disorders research

Publication details

Journal / source
University of Southern Denmark Research Portal (University of Southern Denmark)
Publication date
21 January 2026
Language
EN